Sunday, August 16, 2020

Carlyle Founder's Declaration Partners & COVID-19 Saliva Test

Declaration Partners, the Family Office of Carlyle Group co-founder David Rubenstein, invested in Vault in March 2020.  Vault announced a home COVID-19 test using saliva.  The test must be shipped from Vault, the sample taken in the home under video supervision and be mailed back to Vault for processing.  Mail delays can impact the timeliness of test results.

Rubenstein personally joined Carlyle in profiting from the coronavirus pandemic.  Carlyle has numerous ways to win under COVID-19.

Carlyle affiliates can help infrared screen people in airports for fever (Schneider Electric & HGH), test for COVID antibodies (Ortho Clinical), assist with blood plasma collection (MAK Systems), produce antibody drug conjugate (Piramal Pharma Solutions), ensure the maximum hospital bill for COVID-19 patients (TrustHCS), manufacture Ivermectin treatment (SeQuent Scientific) and make federal coronavirus purchasing something other than a clown show (Unison).

The more Team Trump drags their feet the more the greed and leverage boys can profit.  That's beautiful in a PEU world.